| abstract |
The present invention provides a novel fused ring compound having a GPR40 receptor function-modulating action and useful as an insulin secretion promoter or a prophylactic / therapeutic agent for diabetes and the like. [Each symbol in the formula is as described in the specification. ] Or a salt thereof. The compound or a salt thereof, or a prodrug thereof has a GPR40 receptor function-modulating action, and is useful as a prophylactic / therapeutic agent for insulin secretagogues and diabetes. [Selection figure] None |